Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myelin proteolipid protein (PLP), encoded by the PLP1 gene, is the most abundant transmembrane protein in the central nervous system myelin sheath, playing a critical role in the compaction, stabilization, and maintenance of myelin. In the context of multiple sclerosis (MS), PLP and its immunodominant peptide fragments (such as PLP 139-151) serve as major autoantigens that trigger autoreactive T-cell and B-cell responses, leading to demyelination and neurodegeneration. Consequently, PLP peptides are utilized in antigen-specific tolerization therapies—such as peptide-coupled red blood cells (TOL001) or transdermal skin patches—to selectively desensitize the immune system and restore tolerance without causing broad immunosuppression. Additionally, mutations or duplications of the PLP1 gene lead to Pelizaeus-Merzbacher disease (PMD), a severe, fatal leukodystrophy characterized by hypomyelination due to the accumulation of toxic, misfolded PLP. Therapeutic strategies for PMD include the use of antisense oligonucleotides (such as ION356) to suppress PLP1 expression and mitigate proteotoxic stress in oligodendrocytes.
Antisense oligonucleotide-mediated knockdown of PLP1 pre-mRNA to reduce toxic mutant PLP1 protein expression; Antigen-specific immune tolerance induction (tolerization) to suppress autoreactive T-cell responses against myelin
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myelin proteolipid protein (PLP).